Searching for genetic vulnerabilities in osteosarcoma through genome-wide RNAi screening |
Dana-Farber Cancer Institute / Stuart Orkin, MD |
Innovation Grants |
2012 |
Massachusetts |
Neurofibromatosis Type 1 as a model population for pediatric brain cancer prevention and control research |
Washington University / Kimberly Johnson Ph.D. |
Epidemiology Grants |
2012 |
Missouri |
Targeting the ETS Transcription Factor Rearrangement EWS/FLI in Ewing sarcoma |
Dana-Farber Cancer Institute / Kimberly Stegmaier, MD |
Bridge Grants |
2012 |
Massachusetts |
Racial and Ethnic Disparities in Survival of Children with Neuroblastoma |
University of Chicago / Susan Cohn, MD |
Innovation Grants |
2011 |
Illinois |
Blockade of p53 and Aurora A in Therapy Resistant Neuroblastoma |
University of California San Francisco / William Clay Gustafson, MD, PhD |
'A' Award Grants |
2011 |
California |
A Combinatorial Approach to Target the Tumor-Initiating and Transit Amplifying Cellular Subpopulations in Diffuse Intrinsic Pontine Glioma (DIPG) |
Stanford University / Michelle Monje, MD, PhD |
'A' Award Grants |
2011 |
California |
COPE in Parents of Children Diagnosed with Cancer |
University of Arizona / Gloanna Peek |
Nurse Researcher Grants |
2011 |
Arizona |
The Role of Mxi1 in the Modulation N-Myc Function in Neuroblastoma |
Duke University / Michael Armstrong |
Young Investigator Grants |
2011 |
North Carolina |
Mechanisms of Oncogenic Transformation by TLX1/HOX11 |
University of Michigan / Mark Chiang |
Young Investigator Grants |
2011 |
Michigan |
Clinical Development of RNA Nanoparticle Vaccines Targeting Recurrent Pediatric Brain Cancers |
Duke University / Duane Mitchell, MD, PhD |
Innovation Grants |
2011 |
North Carolina |